In summary, although the CRIP family can regulate EMT, they mainly focus on certain cancer types (such as breast cancer and HCC), lack extensive studies on other cancer types, and mostly rely on the detection of changes in EMT markers while ignoring its dynamic process. This evidence concerns the gene CRIP1 and breast cancer.